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Abstract
Background: Oxidative damage present in obese/overweight mothers may lead to further oxidative stress
conditions or inflammation in maternal and cord blood samples. Thirty-four pregnant women/newborn pairs were
included in this study to assess the presence of oxidative stress biomarkers and their relationship with serum
cytokine concentrations. Oxidative stress biomarkers and antioxidant enzymes were compared between the
mother/offspring pairs. The presence of 27 cytokines was measured in maternal and cord blood samples. Analyses
were initially performed between all mothers and newborns and later between normal weight and mothers with
overweight and obesity, and diabetic/non-diabetic women.
Results: Significant differences were found in biomarker concentrations between mothers and newborns.
Additionally, superoxide-dismutase activity was higher in pre-pregnancy overweight mothers compared to those
with normal weight. Activity for this enzyme was higher in neonates born from mothers with normal pregestational
weight compared with their mothers. Nitrites in overweight/obese mothers were statistically lower than in their
offspring. Maternal free fatty acids, nitrites, carbonylated proteins, malondialdehyde and superoxide dismutase
predicted maternal serum concentrations of IL-4, IL-13, IP-10 and MIP-1β. Arginase activity in maternal plasma was
related to decreased concentrations of IL-4 and IL-1β in cord arterial blood. Increased maternal malondialdehyde
plasma was associated with higher levels of IL-6 and IL-7 in the offspring.
Conclusions: Oxidative stress biomarkers differ between mothers and offspring and can predict maternal and
newborn cytokine concentrations, indicating a potential role for oxidative stress in foetal metabolic and immunologic
programming. Moreover, maternal obesity and diabetes may affect maternal microenvironments, and oxidative stress
related to these can have an impact on the placenta and foetal growth.
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Background
The presence of obesity is especially relevant among
women of reproductive age because of its possible ef-
fects on pregnancy. Women with a higher percentage of
adipose tissue and a body mass index (BMI) higher than
25 kg/m2 before and/or during pregnancy may present
a higher incidence of adverse gestational outcomes, in-
cluding metabolic and anatomic alterations in their
offspring [1]. Maternal obesity impacts placental me-
tabolism and foetal redox balance [2] and increases
the probability of developing complications during
pregnancy, such as preeclampsia and gestational dia-
betes [3]. Moreover, excess adiposity in the mother
may condition metabolic programming of the foetus,
which may reduce insulin sensitivity and may favour
the development of metabolic syndrome. Babies born
from obese mothers have an increased risk of becoming
obese or diabetic later in life [4].
Pregnancy associated with maternal obesity is also re-
lated to maternal systemic inflammatory conditions
and placental inflammation [5], and some authors have
shown that it may also condition an inflammatory en-
vironment for the foetus [6, 7]. Recently, Aye et al. re-
ported that maternal BMI may be associated with
higher maternal cytokine concentrations and activation
of placental inflammatory pathways, although they did
not find changes in foetal systemic inflammatory cyto-
kines [8]. Pantham et al. reported similar findings in
patients with gestational diabetes [5].
The placenta is able to respond to maternal disturbances,
playing an important role in stimuli that participate in
foetal programming [9]. Systemic cytokines, cortisol levels,
hypoxia, and nitrative and oxidative stress are important
factors that may participate in foetal metabolic program-
ming [9–12].
Some pregnancy complications, such as preeclampsia
and gestational diabetes, may be related to maternal oxi-
dative stress, similar to complications found in small for
gestational age newborns who later may develop meta-
bolic syndrome or neurological disorders [13].
Even though foetal programming may be triggered by
multiple “insults”, and although their pathophysiological
mechanisms have yet to be fully elucidated, oxidative
stress in particular has received increased attention. The
objective of this study was to assess the presence of oxi-
dative stress biomarkers, the activity of enzymes related
to oxidative stress and their relationship with cytokine
concentrations in overweight/obese and normal weight,
as well as diabetic and non-diabetic, pregnant women
and their offspring. Blood samples from mothers and their
newborn infants were evaluated for superoxide dismutase,
arginase and glutathione peroxidase activity. Levels of free
fatty acids, lipid peroxidation and protein carbonylation in
plasma were also measured.
Methods
This study was conducted at the National Institute of
Perinatology, a third-level healthcare institution in Mexico
City. The hospital’s ethics and research committees ap-
proved the study before the participant’s enrolment. All
patients signed an informed consent letter, prior to their
enrolment in the study.
Patients and samples
Upon admission to the Labour and Delivery unit,
women who met the inclusion criteria (having a single
non-complicated pregnancy, who did not receive medi-
cation for 3 weeks prior to delivery) and were willing to
participate and sign the informed consent form were en-
rolled in the study. Thirty-four women were included.
Obstetric outcomes and drugs administered during de-
livery were annotated and patients’ clinical and demo-
graphic data were retrieved from medical records. Each
participant was followed until delivery of the placenta.
Maternal blood was obtained by venipuncture prior to
delivery, and the newborn’s blood was obtained after pla-
cental delivery by umbilical cord arterial puncture under
sterile conditions [14]. Blood was collected in heparinized,
mineral-free BD Vacutainer-brand tubes and centrifuged
at 3500 rpm, and erythrocytes and plasma were aliquoted.
Samples were refrigerated immediately for further analysis.
Butylated hydrotoluene (0.2 ml) was added as a conserva-
tive to the samples in order to evaluate antioxidants, lipids
and protein damage.
Quantitation of lipid hydroperoxides (LOOH) in red blood
cell membranes
To evaluate lipid peroxides, we used the assay conditions
described by El-Saadani et al. (13). The test solution
was mixed with a colour reagent of a commercially
available kit for the enzymatic determination of choles-
terol (CHO-iodide; Roche). This assay quantifies lipid
peroxides by testing their ability to convert iodide to
iodine, which can be measured photometrically at 360 nm.
Calibration curves were obtained using peroxides such as
t-butylhydroperoxide.
Malondialdehyde (MDA) quantitation
Aliquots of plasma were used to measure MDA at
586 nm, and the values obtained are expressed as pmol
carbocyanine per mg dry weight (14). 1-Methyl-2-pheny-
lindole (Sigma-Aldrich, MO) was used as a standard.
Assessment of carbonylated proteins (CP)
The quantitation of carbonyl groups is one of the most
useful markers to determine protein damage. One
hundred μl of plasma was combined with 1 ml of 10 mM
2,4-dinitrophenylhydrazine (DNPH) and 2.5 M HCl.
Samples were incubated at room temperature under dark
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conditions and agitated every 15 min during a period of
60 min before being precipitated with 20% trichloroacetic
acid (TCA). Samples were then centrifuged for 10 min at
3500 rpm in order to collect the precipitated protein. The
pellet was washed with 1 ml of 10% TCA. Subsequently,
the precipitate was washed with 3 ml of a mixture of ethy-
lacetate and ethanol (1:1 v/v) in order to eliminate
remaining DNPH. The sample was centrifuged and the
final precipitate was dissolved in 1 ml of 6 M guanidine
chlorhydrate and 20 mM potassium phosphate, and was
then incubated for 10 min at 37 °C. Lastly, the products
were analysed with a spectrophotometer at a wavelength
of 370 nm. The molar extinction coefficient for 2,4-
dinitrophenylhydrazine (ε = 22,000/M−1 cm−1 = 22,000/
106 nmol/mL) was used to calculate the carbonyl con-
centration, which is expressed in nmol of dinitrophe-
nylhydrazine per mg of protein [15].
Arginase enzymatic activity
Activity of arginase in erythrocyte lysates was evaluated
by measuring the release of urea from L-arginine using
Corraliza’s spectrophotometric method [16].
Nitrite quantitation
The concentration of nitrites was quantified in plasma
samples through the indirect method of nitric oxide pro-
duction. Nitrites are considered the final stable product
derived from nitric oxide. The anions were measured ac-
cording to the method described by Miranda [17].
Free fatty acid (FFA) quantitation
The concentration of free fatty acids was assessed using
the colorimetric method developed by Duncombe [18].
Quantitation of erythrocyte antioxidant enzymes
The quantitative analyses of superoxide dismutase (SOD)
and glutathione peroxidase (GSH-Px) in erythrocytes were
performed using an enzyme-linked immunosorbent assay
(ELISA) from Immulite according to the manufacturer’s
requirements and specifications. The results of each assay
are reported according to the concentration of serum pro-
teins in mg/dL using Bradford’s method [19].
Cytokine quantitation
Cytokine concentrations were measured in maternal and
umbilical blood serum using a 27-plex panel cytokine
assay from Bio-Plex (BioRad).
Statistical analyses
Results were analysed with SPSS software (IBM, version
22). Data was tested for normality, linearity and homosce-
dasticity as assumptions for multivariate statistical analyses.
No variables required transformation. Statistical analyses
performed included one-way analyses of variance, paired
and independent samples Student t-tests, multivariate
analyses of variance and covariance and multiple linear
regression analyses. A probability of α-error < 0.05 was
considered to indicate significant results.
Results
Descriptive statistics
Thirty-four pregnant women and their offspring were
included in the study. Maternal age ranged from 16 to
43 years with a mean age of 30.74 ± 1.35 years. Mean
maternal pregestational weight and BMI were 64.36 ±
1.96 kg and 26.38 ± 0.88 kg/m2, respectively. The mean
weight gain throughout pregnancy was 11.97 ± 1.01 kg.
Neonate gestational age at delivery ranged from 34.6 to
41.0 weeks, with a mean of 38.13 ± 0.20 weeks. Mean
newborn weight was 3023 ± 57 g, and the mean height
was 48.57 ± 0.31 cm. Three infants were born preterm
(8.8%).
Fourteen women (41.2%) had a BMI of ≤25 (normal,
according to WHO criteria), four women had a pre-
pregnancy BMI >30 (obesity) and 16 had a BMI between
25.1 and 29.9 (overweight). Thus, twenty (58.8%) partici-
pants were included in the overweight/obesity group be-
cause they had a pre-pregnancy BMI higher than 25 kg/m2.
Eleven (32.4%) women had been diagnosed with dia-
betes prior to gestation or developed gestational diabetes
(GD); the remaining (67.6%) did not have glucose me-
tabolism disorders. Eight diabetic women belonged to
the overweight/obese group and three were in the nor-
mal weight group. Only four (11.8%) of the 11 diabetic
women had abnormal glucose levels during pregnancy.
The majority of the participants (73.5%) received
multivitamin supplementation during pregnancy. Twelve
(35.3%) women received drugs with anti-inflammatory
properties (metformin and acetyl salicylic acid) at some
point during the gestational period.
Inferential statistics
ANOVAs were performed to evaluate differences in ma-
ternal age, weight gain during pregnancy, newborn ges-
tational age and newborn weight in normal weight and
overweight/obese mothers. Mothers with overweight/
obesity gained significantly less weight throughout preg-
nancy compared to normal weight mothers, which was
mainly due to special restriction diets prescribed to over-
weight mothers. Mean differences and significance of
analyses of variance are shown in Fig. 1.
Paired Student t-tests were used to evaluate the activity
of antioxidant enzymes in erythrocytes and the differences
in the mean concentrations of oxidative stress biomarkers
in all maternal peripheral blood and umbilical arterial blood
samples. The 34 mother/offspring pairs were included. Stat-
istical differences were found for all biomarkers that were
evaluated (SOD and GSH-Px, MDA, LOOH, FFA, CP,
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plasma nitrites and arginase activity). SOD and arginase ac-
tivity, CP and nitrites were significantly higher in umbilical
arterial cord blood samples compared with maternal blood
samples. Conversely, GSH-Px, MDA, LOOH and FFA were
lower in the offspring than in their mothers. Means, mean
differences and significance of paired samples t-tests can be
found in Table 1 and Fig. 2.
ANOVAs were also performed to evaluate if biomarkers
were different in term (gestational age ≥37 weeks, N = 31)
and preterm newborns (gestational age <37 weeks, N = 3).
We found that all biomarker concentrations were similar
except for malondialdehyde (MDA) that was reduced by
37.5% in term neonates, compared to those born preterm
(p = 0.025).
To assess if the differences in oxidative stress bio-
markers were also present under different maternal con-
ditions, further analyses evaluated differences between
groups of mothers, groups of neonates, and between
mothers and their offspring. These analyses considered
maternal pre-pregnancy BMI, end of gestation BMI,
Fig. 1 Analysis of variance. Mean differences in maternal age, kg gained during pregnancy, newborn’s gestational age, and newborn weight
between overweight/obese mothers and normal-weight mothers





Mean differences CI 95% Significancea
SOD activity in erythrocytes (U/mL) 261.46 (68.9) 323.82 (59.73) −62.36 −93.8, −30.9 0.000
GSH-Px activity in erythrocytes (U/mL) 617.36 (106.58) 332.38 (64.09) 284.9 241.4, 328.5 0.000
MDA (nmol carbocianine/mg of dry weight) 0.062 (0.017) 0.055 (0.015) 0.006 0.003, 0.008 0.000
LOOH in red blood membranes
(nmol l/mg of dry weight)
0.21 (0.05) 0.11 (0.05) 0.09 0.076, 0.121 0.000
FFA (nmol/mL) 868.63 (188.28) 261.92 (62.49) 606.7 542.3, 671.0 0.000
CP (nmol DNPH/mg of protein) 2.32 (0.87) 3.31 (1.34) −0.99 −1.43, −0.55 0.000
Nitrites (nmol NO3/mL) 8.09 (3.87) 11.29 (3.67) −3.19 −4.99, −1.39 0.001
Arginase activity in erythrocytes
(nmol/mg of protein/min)
7.08 (1.96) 13.29 (3.09) −6,21 −7.28, −5.14 0.000
aPaired-samples t Student test
SOD Superoxide dismutase, GSH-Px Glutathione peroxidase, MDA Malondialdehyde, LOOH Lipid-hydroperoxides, FFA Free fatty acid, CP Carbonylated proteins,
DNPH dinitrophenylhydrazine
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maternal vitamin supplementation, use of drugs with
anti-inflammatory activity during pregnancy, the presence
of diabetes, and the presence of hyperglycaemia during
pregnancy. For the evaluation of mean differences between
groups of mothers and groups of neonates, independent
samples Student t-tests were performed. To evaluate mean
differences between mother and offspring in different con-
ditions, paired samples Student t-tests were used.
As previously mentioned, SOD activity and nitrite
concentrations were significantly lower in mothers at the
end of pregnancy compared to their newborn infants.
However, when comparing these biomarkers and consid-
ering pre-pregnancy maternal BMI, significant differences
were found in SOD concentrations between women with
obesity and women with normal weight (311 U/mL vs 206
U/mL, p = 0.019), and between women with overweight
and those with normal weight (SOD 289 vs 206 U/mL,
p = 0.002). Since women with overweight and obesity
had similar behaviors in terms of biomarker concentra-
tions, it was decided to group the four women with
obesity along with the women in the overweight group.
Overall, we found that SOD activity was significantly
higher in overweight/obese mothers compared to those
with normal weight. This behaviour was not replicated
in offspring born to overweight and normal weight
mothers as they had similar SOD activity. There was no
significant difference in SOD activity in overweight
mother/newborn pairs, yet SOD activity was significantly
higher in babies from normal weight mothers compared
to their mothers. With respect to nitrites, no differences
between normal weight and overweight mothers were
found. However, in mother/offspring analyses, nitrites in
overweight mothers were statistically lower than their
babies. Lowest nitrite levels were found in mothers
with a BMI ≥ 25.1 kg/m2. No differences were found in
nitrite concentrations in normal weight mothers and
their neonates.
Biomarkers were also compared in groups according
to BMI at the end of pregnancy. Significant differences
in MDA and nitrite concentrations between mothers
and their offspring (Table 1) were not found in mothers
with normal weight at the end of pregnancy. Moreover,
MDA concentration was significantly increased in mothers
with a BMI ≥ 25.1 kg/m2 at the end of pregnancy com-
pared to their offspring, while nitrite concentration was
higher in the offspring in the same group (Fig. 3).
The majority of participants (74%) reported multivita-
min consumption during pregnancy. The type, brand
and combination of vitamins differed slightly among pa-
tients, although all prescribed brands included folic acid.
Researchers were not able to collect information regarding
the dosage or duration of multivitamin consumption. A
dichotomous variable regarding vitamin supplementation
(yes/no) was used for analyses. It is unknown why nine
participants did not receive vitamin supplementation dur-
ing pregnancy, as all pregnant women are prescribed
Fig. 2 Oxidative stress biomarkers in mother/offspring pairs. Means and standard deviations (n = 34). Differences evaluated by paired-samples
t Student test. SOD = Superoxide dismutase, GSH-Px = Glutathione peroxidase, MDA =malondialdehyde, LOOH = Lipid-hydroperoxides, FFA = Free
fatty acid, CP = Carbonylated proteins. SOD, GSH-Px and ARG values reflect enzymatic activity in erythrocytes (nmol/mg of protein or U/mL)
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multivitamin supplementation according to the hospital’s
protocol. Women, who had multivitamin supplementation
during pregnancy, as well as their offspring, had non-
significantly lower levels of MDA than those participants
who did not receive supplementation. Interestingly, MDA
concentrations were similar between mothers and babies
who did not receive vitamin supplementation, but there
were significant differences in MDA concentrations be-
tween mothers who were prescribed supplementation and
their babies, where MDA was lower in the offspring. Add-
itionally, mothers who received multivitamin supplementa-
tion had significantly lower concentrations of CP (reflecting
less oxidative stress) compared to those who did not. How-
ever, a reduction in CP was not observed in the offspring,
Fig. 3 Mean differences of oxidative stress biomarkers in the mother/offspring groups and in mothers vs. neonates, according to BMI, diabetes status,
and the use of multivitamins and anti-inflammatory drugs. (n = 34 mother/offspring pairs). SOD = Superoxide dismutase (U/mL), CP = Carbonylated
proteins (nmol DNPH/mg of protein), Nitrites (nmol/mg protein/min), Arg = Arginase activity (nmol/mg proteins/min), MDA =Malondialdehyde
(nmol of carbocyanine/mg of dry weight), NDPH= dinitrophenylhydrazine. a Pre-pregnancy BMI. b BMI at the end of pregnancy. c Multi-vitamin
consumption during pregnancy. d Use of anti-inflammatories during pregnancy. e Diabetes during pregnancy. f Hyperglycaemia during pregnancy
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as babies from mothers who received vitamin supplementa-
tion had significantly higher concentrations of CP than
their mothers. This is similar to what was observed in over-
all concentrations of CP between mothers and newborns in
the first analysis shown in Table 1, where babies had signifi-
cantly more CP than their mothers. Apparently, CP reduc-
tion after vitamin supplementation has a relevant impact in
the mother but not in the offspring. Regarding nitrites,
mothers who received multivitamin supplementation (n =
25) had significantly lower nitrite concentrations than
those who did not receive supplements. This result was
not replicated in the umbilical cord samples.
Drugs with anti-inflammatory properties, such as met-
formin and acetyl salicylic acid (ASA), were prescribed
by physicians to some patients for glycaemic control and
preeclampsia prevention, respectively. Paired sample Stu-
dent t-tests showed that SOD activity was significantly
higher in babies from mothers who did not receive met-
formin or ASA compared to maternal samples. Although
without statistical significance, SOD activity was lower in
the offspring of women who received metformin or ASA.
No differences in SOD activity were observed when com-
paring maternal samples or cord blood samples between
the groups who received these drugs and those that did
not. Similarly, CP was higher in cord blood samples com-
pared to maternal samples. CP was non-significantly lower
in the neonates of mothers who received metformin or
ASA. Babies born from mothers who did not receive drugs
with anti-inflammatory activity had significantly higher
levels of CP compared with their mothers.
Multivariate analyses of variance and covariance were per-
formed to assess differences in oxidative stress biomarkers
in mothers with or without diabetes. Significant differences
were found for SOD activity (F(1,31) = 12.053; p= 0.002;
partial eta squared = 0.28; mean differences 311.06 ± 72.69
vs. 2374.32 ± 52.66 pg/mL) and arginase activity (F(1,31) =
6.39; p= 0.017; partial eta squared = 0.17; mean differences
981.37 ± 173.97 vs. 817.07 ± 176.97 pg/mL). Patients with
diabetes had increased SOD and arginase activity. How-
ever, when controlling for the use of insulin or metfor-
min in these patients, the differences in SOD persisted
but a statistically significant difference was not found for
arginase in the covariance analysis (F(1,30) = 4.14; p =
0.051; partial eta squared = 0.12). Additionally, paired -
samples analyses between cord blood samples and mater-
nal samples showed a significantly higher SOD activity in
neonates of non-diabetic mothers than their mothers.
From the eleven participants (32.4%) who presented a
glucose metabolism disorder during pregnancy, three had
pre-gestational diabetes mellitus (PGDM), eight developed
gestational diabetes (GD) and 23 were non-diabetic (ND).
Differences in all biomarkers were evaluated by performing
analyses of variance. Only SOD activity in erythrocytes was
found to be significantly higher in mothers with PGDM
and GD compared to ND (p = 0.045 and 0.035, respect-
ively), and free fatty acid concentration was significantly
higher in women with GD compared with ND (Mean Dif-
ference = 277.7, CI 95% = 95.6, 459, p = 0.004). There were
no significant differences in the rest of the biomarkers
studied between these three groups.
Even though only four out of the 11 diabetic women
who participated in this study had abnormal glucose
concentrations throughout pregnancy, the results seem
sufficiently strong to show the possible effect of hyper-
glycaemia on some oxidative stress biomarkers in
mothers and their newborns. SOD activity was signifi-
cantly higher in hyperglycaemic mothers than those
mothers with normal glucose levels.
Alternatively, SOD activity was 19% higher in newborns
of normoglycaemic mothers compared to their mothers.
This difference was not observed when comparing SOD ac-
tivity between mother and baby in the hyperglycaemic
group. Plasma nitrites were significantly higher (28%) in ba-
bies born from normoglycaemic mothers compared to those
of their mothers. This difference was not found in newborns
whose mothers were hyperglycaemic during pregnancy.
In the first minutes of extra-uterine life, newborns had
significantly higher arginase activity compared to their
mothers. However, this was only shown in offspring of
normoglycaemic mothers. Means, mean differences and
significance of independent samples and paired samples
t-tests between groups can be found in Fig. 3.
Multiple regression analyses were conducted to evalu-
ate which independent variables of maternal oxidative
stress (LOOH, MDA, FFA, arginase, CP, nitrites, SOD,
GSH-Px) could predict concentrations of 27 different
cytokine levels in maternal plasma and in the offspring.
Regression analyses indicated that maternal FFA, ni-
trites, CP, MDA and SOD can affect maternal serum
concentrations of IL-4, IL-13, IP-10 and MIP1β. Regres-
sion coefficients for significant results are presented in
Table 2. Likewise, multiple regression results showed that
maternal concentrations of MDA, FFA, LOOH, CP, ni-
trites, arginase and GSH-Px may predict concentrations of
several cytokines in the offspring. Arginase activity in the
mother was related to decreased plasma concentrations of
IL-4 and IL-1β. Moreover, increased MDA maternal
plasma concentrations were associated with higher levels
of IL-6 and IL-7 and to lower levels of G-CSF and
RANTES in the baby. The presence of maternal serum
free fatty acids was also related to lower levels of G-CSF
and RANTES in maternal plasma. Regression coefficients
for significant results are presented in Table 3.
Discussion
Oxidative stress may be present at the maternal/foetal
interphase in early pregnancy. Although it has been im-
plicated in the normal development of the placenta, it
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may also participate in the pathophysiology of different
pregnancy complications [20, 21] because the presence
of oxidative stress biomarkers may lead to alterations
in the maternal blood supply to the placenta or to in-
flammation [20].
We found that some oxidative stress biomarkers in-
creased and some decreased in newborns compared with
their mothers. SOD, arginase, CP and nitrites were higher
in overall cord blood samples compared to maternal sam-
ples. In contrast, GSH-Px, MDA, LOOH and FFA levels
in neonates were lower than in those of their maternal
counterparts. This finding may indicate a buffering role
for oxidative stress by the placenta. Giuffrè et al. found
that GSH levels were increased in babies born by vaginal
delivery, as well as being positively correlated to gesta-
tional age [22]. In this study, lower levels of GSH-Px were
found in newborns compared with their mothers. Our
population may not be comparable to that of Giufreé as
gestational age varied in our population, babies were deliv-
ered by caesarean section, and many confounding mater-
nal variables were considered within the participants.
Even though overall SOD activity was higher in mothers
compared to their babies in this study, SOD was predomin-
antly higher in the group of overweight/obese mothers
compared to the normal weight group. Conversely, SOD
activity in newborns was higher in those born from normal
weight mothers compared to their mothers. Casado et al.
also found higher SOD activity in healthy newborns [23].
However, lower SOD activity may also be present in new-
borns with asphyxia, intrauterine asphyxia and peroxidation
conditions [24]. In this study, babies born from overweight/
obese mothers had non-significantly lower SOD activity
than those born from normal weight mothers. Moreover,
increased lipid peroxidation was found in preterm new-
borns compared to those born at term, a similar finding to
previous reports in the literature [25].
Table 2 Multiple linear regression results for prediction of maternal serum cytokines and chemokines by maternal serum oxidative
stress biomarkers (n = 34)
Oxidative Stress biomarkera (Maternal plasma) Cytokine/Chemokine (Maternal plasma) B SE β Significance CI 95%
FFA IL-4 0.003 0.001 0.417 0.028 0.000, 0.006
MIP-1B 0.031 0.008 0.493 0.001 0.014, 0.048
Nitrites IP-10 −33.21 15.93 −0.357 0.04 0.799, 1.251
MIP-1B 0.885 0.402 0.294 0.03 0.056, 1.715
CP MIP-1B −6.320 2.003 −0.473 0.004 −10.453, −2.187
MDA IL-13 −79.02 28.97 −0.534 0.01 −138.82, −19.21
SOD MIP-1B −0.068 0.024 −0.399 0.009 −0.117, −0.019
aOnly significant data is shown. FFA Free fatty acids, CP Carbonylated proteins, MDA Malondialdehyde, SOD Superoxide dismutase, SE standard error,
β beta coefficient
Table 3 Multiple linear regression results for prediction of umbilical cord blood cytokines and chemokines by maternal serum
oxidative stress biomarkers (n = 34)
Maternal oxidative stress biomarker Umbilical cord blood cytokines
and chemokinesa
B SEβ β Significance CI 95%
MDA G-CSF −909.13 392.25 −0.452 0.02 −1718.7, −99.5
IP-10 7152.41 2600.86 0.539 0.01 1784.4, 12520.3
IL-7 −395.88 183.77 −0.491 0.04 −775.1, −16.5
IL-6 59.55 24.76 0.469 0.02 8.4, 110.6
IL-5 25.28 10.08 0.497 0.01 4.4, 46.0
RANTES −77082.9 28082.5 −0.457 0.01 −13542, −19123
FFA G-CSF −0.070 0.031 −0.376 0.03 −0.13, −0.006
RANTES −5.612 2.22 −0.358 0.01 −10.2, −1.0
CP IL-13 0.823 0.348 0.517 0.02 0.1, 1.5
Nitrites IL-9 417.22 199.89 0.401 0.04 4.6, 829.7
Arginase IL-4 −0.405 0.154 −0.512 0.01 −0.7, −0.08
IL-1β −0.082 0.033 −0.457 0.01 −0.1, −0.01
GSH-Px RANTES 12.31 4.28 0.447 0.008 3.4, 21.1
aOnly variables with statistical significance are shown
SOD Superoxide Dismutase, GSH-Px Glutathion Peroxidase, MDA Malondialdehyde, CP Carbonylated proteins, FFA Free fatty acids, SEβ Coefficient β standard error,
β Standardized coefficient. B Unstandardized regression coefficients
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Additionally, we found that overweight and obese
mothers had the lowest nitrite levels, thus reflecting
lower nitric oxide production. Petrella et al. also found
lower nitrite production in overweight/obese pregnant
women, although these observations were seen in re-
sponse to L-arginine infusions [26]. In a mouse obesity
model, nitrite production was significantly higher in
obese vs. lean mice [27]. Other authors report a posi-
tive correlation between nitric oxide concentrations
and body fat, but a poor correlation with serum lipid
concentrations [28], which is different to this study’s
findings. However, the previously mentioned results are
from non-pregnant women and mice. Given the import-
ance of nitric oxide and nitrites in vascular physiology,
their role in overweight/obese pregnant women clearly
needs further investigation [9]. Finding low levels of nitric
oxide precursors (nitrites) in the plasma of overweight or
obese mothers is relevant because none of them developed
gestational hypertension or preeclampsia/eclampsia (which
was an exclusion criterion in our study). Moreover, this ef-
fect was increased when the mother had multi-vitamin
consumption during pregnancy. On the other hand, multi-
vitamin supplementation in these patients was also related
to a decreased harm to lipids (in the form of MDA) in
maternal and cord blood samples. This study’s results
support the importance of vitamin supplementation
during pregnancy with regard to oxidative stress, as
MDA was lower in newborn infants of mothers who had
multivitamin supplementation. However, a decrease in CP
was only found in the mothers who had supplementation,
but not in their babies. Therefore, in our study population,
vitamin supplementation protected the mother from
protein carbonylation, but not the offspring. The effect
of vitamin supplementation in reducing MDA concen-
trations and protein carbonylation has previously been
reported [29].
Oxidative stress has also been linked with the presence
of diabetes mellitus [30]. Increased SOD and arginase
activity in pregnant diabetic patients were observed in
this study. Coughlan et al. also found increased activity
of SOD, but also reported increased carbonyl concentra-
tions in women with gestational diabetes [31]. Conversely,
Djordjevic et al. found decreased SOD activity in diabetic
pregnant women compared to normal pregnant women
and non-pregnant women [32]. Arginase has been pro-
posed as a diagnostic biomarker for diabetes mellitus in
rat models and in human diabetic subjects because it
correlates with blood glucose levels [33, 34]. In this
study, we found that differences in arginase activity be-
tween diabetic and non-diabetic mothers disappeared
when controlling for the effect of the use of metformin
and insulin, showing that these may affect arginase ac-
tivity, similar to a finding by Kashyap et al. [34]. More-
over, Giri et al. found higher arginase activity in the
cord blood of gestational diabetic mothers compared to
their controls [35]. The offspring of mothers with nor-
mal serum glucose, presented higher levels of arginase,
compared to their mothers. As this enzyme participates
in the regulation of nitric oxide synthesis by reducing
the bioavailability of arginine for nitric oxide produc-
tion [36], this is a relevant finding. Nitric oxide is an
important regulator of circulatory changes that occur
during fetal life and in the newborn.
Oxidative stress may also modulate cytokine production
[37]. Regression analyses in this study showed that
maternal FFA was related to higher IL-4 and MIP-1β
production in the mother. Additionally, nitrites were
associated to increased MIP-1β, but with a decrease in
IP-10 concentration. The biomarker in this study that
was most associated with inflammatory cytokines was
the presence of free fatty acids in pregnant women,
which is consistent with the findings of several studies
[38]. The relationship between obesity-related bio-
markers and inflammatory microenvironments in
pregnancy has been described previously [39].
Maternal oxidative stress biomarkers may also be re-
lated to changes in cytokine concentrations in newborns.
In this study, arginase activity was associated with a down
regulation of IL-1β and IL-4.
Although MDA and LOOH were not promoters of in-
flammatory cytokines in the mother, they were related to
the offspring’s inflammatory cytokines. Oxidative stress
may influence inflammatory pathways in the newborn, but
there is scarce information regarding the role of maternal
oxidative stress biomarkers in promoting inflammatory
conditions in the offspring. This study shows important
differences within oxidative stress biomarkers and the re-
lationship between these and maternal and cord blood cy-
tokines. However, our study presents limitations. Due to
the complexity of the sample collection process, only 34
pairs were included in this study. Future studies with lar-
ger samples sizes may reveal further information regarding
these public health problems.
Conclusion
Maternal obesity influences oxidative stress and meta-
bolic adjustments during pregnancy, thus affecting the
placenta and foetal growth, and may also influence im-
mune system activation. Multivitamin supplementation
may protect the mother from oxidative stress, but not
necessarily her baby.
Our findings support that obesity and diabetes can
affect maternal microenvironments, and that oxidative
stress related to these may affect metabolic and immuno-
logic programming of the baby. Further research regarding
metabolic and oxidative stress, and the immunological
consequences of obesity and gestational diabetes on ma-
ternal and newborn health is warranted.
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